FOLD Amicus Therapeutics, Inc.
Healthcare$14.49+0.00%ClosedMarket Cap: $4.55B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$14.50
Target (Median)
$14.50
Target Range
$14.50 - $14.50
Upside from current price: 0.1%
Rating Distribution
0 Strong Buy0 Buy7 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-01-22 | Jefferies | downgrade | Hold | Buy |
| 2025-12-29 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2025-12-22 | Citigroup | downgrade | Neutral | Buy |
| 2025-12-19 | Needham | downgrade | Hold | Buy |
| 2025-12-19 | Cantor Fitzgerald | downgrade | Neutral | Overweight |
| 2025-11-06 | JP Morgan | maintain | Overweight | Overweight |
| 2025-11-05 | Goldman Sachs | maintain | Neutral | Neutral |
| 2025-09-18 | Needham | upgrade | Buy | Hold |
| 2025-07-17 | Morgan Stanley | upgrade | Overweight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.64 | $896.5M | 3 |
| Sun Dec 31 | $0.91 | $1.10B | 2 |
| Mon Dec 31 | $1.36 | $1.31B | 1 |
| Tue Dec 31 | $1.67 | $1.47B | 1 |